Test Catalog Specimen Rejection Information Update - Insights
The “Reject Due To” information contained in our online test catalog is being updated to provide greater clarity around rejection standards.
Allan Jaffe, M.D., Consultant and Chair of Mayo Clinic’s Division of Clinical Core Laboratory Services, with a joint appointment in the Division of Cardiovascular Diseases, will be presenting a webinar on the implementation of a...
Elitza Theel, Ph.D., Director of the Infectious Diseases Serology Laboratory, discusses eastern equine encephalitis virus, which is spread via mosquito bite.
Vaping-Associated Lung Injury May Be Caused by Toxic Chemical Fumes, Study Finds - Insights
A Mayo Clinic study published in The New England Journal of Medicine finds that lung injuries from vaping most likely are caused by direct toxicity or tissue damage from noxious chemical fumes.
Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic Leukemia - Insights
Curtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.
Jane Hermansen, MT(ASCP), on What We Learned from the Promise of Theranos - Insights
Jane Hermansen, Manager, Outreach and Network Development, is featured on the cover of October’s MedicalLab Management where she takes a good look at lessons to be learned from Theranos.
The purpose of the panel was to provide insight into how some health care systems are paving the way for value-based care.
Matthew Binnicker, Ph.D., on Testing for Viral Gastroenteritis - Insights
Matthew Binnicker, Ph.D., Director of the Clinical Virology Laboratory in the Division of Clinical Microbiology at Mayo Clinic, recently spoke with Consultant360 regarding testing for viral gastroenteritis.
Maria Alice Willrich, Ph.D., Discusses Therapeutic Monoclonal Antibodies - Insights
Maria Alice Willrich, Ph.D., was featured in an article in "360Dx" discussing therapeutic monoclonal antibodies (t-mAbs).
Bobbi Pritt, M.D., Advises Pathologists on Parasite Identification - Insights
Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Laboratory Medicine and Pathology, was recently featured in an article in CAP TODAY...